Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.155 EUR | -2.53% | +0.43% | -30.21% |
May. 27 | Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development | AN |
May. 20 | Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 2.2M 2.37M | Sales 2025 * | 3.35M 3.61M | Capitalization | 25.18M 27.14M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.16M | Net income 2025 * | -2M -2.16M | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | 1.27M 1.37M | Net cash position 2025 * | 1.19M 1.29M | EV / Sales 2025 * | 7.16 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
1 day | -2.53% | ||
1 week | +0.43% | ||
Current month | +0.43% | ||
1 month | -0.86% | ||
3 months | -24.26% | ||
6 months | -34.75% | ||
Current year | -30.21% |
Managers | Title | Age | Since |
---|---|---|---|
Bruna Marini
FOU | Founder | 39 | - |
Rudy Ippodrino
FOU | Founder | - | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Luigi Colombo
BRD | Director/Board Member | 61 | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Laura Amadesi
BRD | Director/Board Member | 56 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.155 | -2.53% | 3,000 |
24-06-06 | 1.185 | +3.49% | 52,000 |
24-06-05 | 1.145 | +0.88% | 19,000 |
24-06-04 | 1.135 | -1.73% | 3,000 |
24-06-03 | 1.155 | +0.43% | 24,000 |
Real-time Borsa Italiana, June 07, 2024 at 11:44 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.21% | 27.22M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- UBM Stock